CM, Langston JW (1998a) Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease. Neurology 50:1136-1137 Chan P, Tanner CM, Jiang X, Langston JW (1998b) Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. Neurology 50:513-514 Letters to the Editor
Summary. We have studied the expression of the silent b-thalassaemia term+6 (C fi G) mutation, at nucleotide 6 after the stop codon within the human b-globin 3¢ untranslated regions (3¢UTR), by stable transfection in murine erythroleukaemia (MEL) cells. Steady state mRNA levels from transfected MEL cells containing the term+6 mutant allele were reduced by 52-60%, compared with those obtained from the normal b-globin gene, in both total and cytoplasmic RNA fractions, showing that the mutation itself is responsible for the similar data obtained from patients. Upon analysis of nuclear RNA, the term+6 mutation was found to also lower the ratio of cleaved/uncleaved transcripts by 22-30%, thus revealing that it interferes with correct 3¢-end formation of b-globin mRNA. The term+6 mutation lies within a polypyrimidine track, similar to that in the b-intervening sequence II (b-IVSII), which is known to be an important contributor to the promotion of premRNA 3¢-end formation. We propose that the two polypyrimidine tracks flanking the translated region of exon III of the human b-globin gene may co-operate during b-globin mRNA biogenesis.
SummaryThe mechanisms by which mutations within the 5¢ untranslated region (UTR) of the human b-globin gene (HBB) cause thalassaemia are currently not well understood. We present here the first comprehensive comparative functional analysis of four 'silent' mutations in the human b-globin 5¢UTR, namely: +10()T), +22(G fi A), +33(C fi G) and +(40-43)()AAAC), which are present in patients with b-thalassaemia intermedia. Expression of these genes under the control of the b-globin locus control region in stable transfected murine erythroleukaemia cells showed that all four mutations decreased steady state levels of mRNA to 61AE6%, 68%, 85AE2% and 70AE6%, respectively, compared with the wildtype gene. These mutations did not interfere with either mRNA transport from the nucleus to the cytoplasm, 3¢ end processing or mRNA stability. Nuclear run-on experiments demonstrated that mutations +10()T) and +33(C fi G) reduced the rate of transcription to a degree that fully accounted for the observed lower level of mRNA accumulation, suggesting a disruption of downstream promoter sequences. Interestingly, mutation +22(G fi A) decreased the rate of transcription to a low degree, indicating the existence of a mechanism that acts post-transcriptionally. Generally, our data demonstrated the significance of functionally analysing mutants of this type in the presence of a full complement of transcriptional regulatory elements within a stably integrated chromatin context in an erythroid cell environment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.